South Africa Bispecific Antibodies Market Size & Outlook, 2025-2031
South Africa Bispecific Antibodies Market Size
According to Straits Research analysis, the South Africa Bispecific Antibodies Market was valued at USD 32.78 Million in 2024 and is projected to reach USD 105.95 Million by 2031, expanding at a CAGR of 19.2% during the forecast period. The high growth trajectory is primarily driven by the diverse applications of bispecific antibodies in the healthcare and pharmaceutical sector, majorly for providing superior treatment options for cancer and immunological disorders. Agricultural applications in pest management and crop protection are also contributing to this growing demand. Technological advancements and the potential of green production methods are setting a new trend in the market. The South African market, with its significant investment in R&D, is also exploring opportunities in the export market. Given the current trends, South Africa is progressively positioning itself as a significant player in the global bispecific antibodies market.
Source: Straits Research Analysis Company Publications, Primary Interviews.
South Africa Bispecific Antibodies Market Highlights
- Bi-specific T-cell engager held the leading position among Type segments in 2024, based on market size.
- Bi-specific T-cell engager is projected to post the fastest growth rate, sustaining its position as the most attractive Type segment during the forecast horizon.
- In 2024, South Africa accounted for 0.59% of the global bispecific antibodies market size.
- By 2031, United States is expected to lead the global bispecific antibodies market in terms of market size.
- Within Middle East And Africa, Rest of MEA is projected to dominate the regional bispecific antibodies market size by 2031.
- South Africa is identified as the fastest-growing market in Middle East And Africa, anticipated to reach USD 25.81 Million by 2031.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2031 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2031 |
| Market Size In 2024 | USD 32.78 Million |
| Market Size In 2031 | USD 105.95 Million |
| Largest segment | Bi-specific T-cell engager |
| Fastest segment | Bi-specific T-cell engager |
| Units | Revenue in USD Million |
| CAGR | 19.2% (2025-2031) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
South Africa Bispecific Antibodies Market Share By Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Type |
|
| Therapeutic Areas |
|
| Target |
|
South Africa Bispecific Antibodies Market By Type 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
South Africa Bispecific Antibodies Market By Therapeutic Areas 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
South Africa Bispecific Antibodies Market By Target 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
